Joseph K. Belanoff
2012
In 2012, Joseph K. Belanoff earned a total compensation of $962.2K as Chief Executive Officer and President at Corcept Therapeutics, a 73% decrease compared to previous year.
Compensation breakdown
| Bonus | $481,097 |
|---|---|
| Salary | $481,097 |
| Total | $962,194 |
Belanoff received $481.1K in bonus, accounting for 50% of the total pay in 2012.
Belanoff also received $481.1K in salary.
Rankings
In 2012, Joseph K. Belanoff's compensation ranked 6,262nd out of 11,487 executives tracked by ExecPay. In other words, Belanoff earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,262 out of 11,487 | 46th |
Division Manufacturing | 2,235 out of 4,253 | 47th |
Major group Chemicals And Allied Products | 562 out of 1,203 | 53rd |
Industry group Drugs | 382 out of 925 | 59th |
Industry Pharmaceutical Preparations | 300 out of 700 | 57th |
Source: SEC filing on April 20, 2015.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2012.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019